Goldman Sachs’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $749K | Sell |
|
|||||
|
2025
Q2 | $1.57M | Sell |
|
|||||
|
2025
Q1 | $1.65M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Sell |
|
|||||
|
2024
Q3 | $947K | Buy |
|
|||||
|
2024
Q2 | $345K | Buy |
|
|||||
|
2024
Q1 | $111K | Sell |
|
|||||
|
2023
Q4 | $210K | Sell |
|
|||||
|
2023
Q3 | $260K | Buy |
|
|||||
|
2023
Q2 | $311K | Buy |
|
|||||
|
2023
Q1 | $251K | Sell |
|
|||||
|
2022
Q4 | $335K | Buy |
|
|||||
|
2022
Q3 | $272K | Sell |
|
|||||
|
2022
Q2 | $388K | Sell |
|
|||||
|
2022
Q1 | $698K | Buy |
|
|||||
|
2021
Q4 | $710K | Buy |
|
|||||
|
2021
Q3 | $426K | Sell |
|
|||||
|
2021
Q2 | $2.46M | Buy |
|